TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 67.98%-5.55M | ---- | -57.11%-17.34M | ---- | 36.26%-11.04M | ---- | -24.58%-17.32M | ---- | -152.47%-13.9M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 32.81%-43K | ---- | 61.21%-64K | ---- | -20.44%-165K | ---- | 27.89%-137K | ---- | 1.04%-190K |
Interest expense - adjustment | ---- | 117.10%1.42M | ---- | 50.57%655K | ---- | -31.71%435K | ---- | -16.07%637K | ---- | 234.36%759K |
Impairment and provisions: | ---- | -325.46%-6.36M | ---- | 59.50%2.82M | ---- | -61.46%1.77M | ---- | 328.29%4.59M | ---- | 733.73%1.07M |
-Impairmen of inventory (reversal) | ---- | -459.95%-5.52M | ---- | -30.73%1.53M | ---- | 89.47%2.21M | ---- | 324.73%1.17M | ---- | 262.72%275K |
-Impairment of trade receivables (reversal) | ---- | -165.27%-840K | ---- | --1.29M | ---- | ---- | ---- | 329.52%3.42M | ---- | --796K |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---445K | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | 1,613.89%2.18M | ---- | 78.41%-144K | ---- | 81.55%-667K | ---- | -2,702.33%-3.62M | ---- | -26.47%-129K |
-Other fair value changes | ---- | 1,613.89%2.18M | ---- | 78.41%-144K | ---- | 81.55%-667K | ---- | -2,702.33%-3.62M | ---- | -26.47%-129K |
Depreciation and amortization: | ---- | 7.65%1.08M | ---- | -15.25%1.01M | ---- | -60.77%1.19M | ---- | -32.23%3.03M | ---- | 308.88%4.47M |
-Amortization of intangible assets | ---- | -43.27%118K | ---- | 1.96%208K | ---- | -11.30%204K | ---- | -22.82%230K | ---- | 51.27%298K |
Unrealized exchange loss (gain) | ---- | -85.17%439K | ---- | 371.90%2.96M | ---- | 54.72%-1.09M | ---- | -439.21%-2.41M | ---- | -83.75%709K |
Special items | ---- | ---- | ---- | -476.47%-64K | ---- | 111.26%17K | ---- | -938.89%-151K | ---- | -92.31%18K |
Operating profit before the change of operating capital | ---- | 32.86%-6.83M | ---- | -6.49%-10.17M | ---- | 37.87%-9.55M | ---- | -113.61%-15.38M | ---- | -13,229.63%-7.2M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -4.90%7.22M | ---- | 212.69%7.59M | ---- | -189.79%-6.74M | ---- | 3,213.69%7.5M | ---- | -103.82%-241K |
Accounts receivable (increase)decrease | ---- | -163.58%-2.85M | ---- | 145.57%4.49M | ---- | -78.43%1.83M | ---- | 859.50%8.48M | ---- | -112.13%-1.12M |
Accounts payable increase (decrease) | ---- | 67.20%-1.07M | ---- | -171.21%-3.26M | ---- | 502.55%4.58M | ---- | -173.23%-1.14M | ---- | 105.52%1.55M |
Special items for working capital changes | ---- | 104.87%2.19M | ---- | 733.59%1.07M | ---- | -96.56%128K | ---- | 193.59%3.73M | ---- | -632.22%-3.98M |
Cash from business operations | ---- | -370.98%-1.35M | ---- | 97.07%-286K | ---- | -405.58%-9.75M | ---- | 129.07%3.19M | ---- | 8.27%-10.98M |
Other taxs | ---- | ---32K | ---- | ---- | ---- | -91.90%59K | ---- | 133.00%728K | ---- | 51.96%-2.21M |
Interest paid - operating | ---- | -56.95%-1.03M | ---- | -54.85%-655K | ---- | 11.51%-423K | ---- | 22.65%-478K | ---- | -172.25%-618K |
Special items of business | -281.09%-967K | ---- | 29.61%534K | ---- | 58.46%412K | ---- | -89.17%260K | ---- | 342.04%2.4M | ---- |
Net cash from operations | -281.09%-967K | -155.79%-2.41M | 29.61%534K | 90.70%-941K | 58.46%412K | -393.96%-10.12M | -89.17%260K | 124.93%3.44M | 342.04%2.4M | 17.78%-13.81M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -32.81%43K | ---- | -61.21%64K | ---- | 20.44%165K | ---- | -27.89%137K | ---- | -1.04%190K |
Purchase of fixed assets | ---- | ---330K | ---- | ---- | ---- | ---230K | ---- | ---- | ---- | 73.57%-440K |
Purchase of intangible assets | ---- | ---- | ---- | -14.29%-16K | ---- | ---14K | ---- | ---- | ---- | 72.74%-217K |
Other items in the investment business | 1,150.00%21K | ---- | -128.57%-2K | ---- | 106.31%7K | ---- | -341.30%-111K | ---- | 100.56%46K | ---- |
Net cash from investment operations | 1,150.00%21K | -697.92%-287K | -128.57%-2K | 160.76%48K | 106.31%7K | -157.66%-79K | -341.30%-111K | 129.34%137K | 100.56%46K | 79.42%-467K |
Net cash before financing | -277.82%-946K | -201.68%-2.69M | 26.97%532K | 91.24%-893K | 181.21%419K | -384.91%-10.2M | -93.91%149K | 125.08%3.58M | 126.75%2.45M | 25.12%-14.27M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -4.42%30.91M | ---- | 7.39%32.34M | ---- | 10.52%30.11M | ---- | 73.79%27.25M | ---- | --15.68M |
Refund | ---- | -12.37%-29.48M | ---- | 7.26%-26.24M | ---- | -27.16%-28.29M | ---- | -136.52%-22.25M | ---- | 56.64%-9.41M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --490K |
Other items of the financing business | -4.94%-2.53M | ---- | -243.42%-2.41M | ---- | 529.41%1.68M | ---- | -136.34%-391K | ---- | -69.94%1.08M | ---- |
Net cash from financing operations | -4.94%-2.53M | -90.39%547K | -243.42%-2.41M | 363.68%5.69M | 529.41%1.68M | -62.84%1.23M | -136.34%-391K | -9.33%3.31M | -69.94%1.08M | -79.52%3.65M |
Effect of rate | ---- | -97.06%-67K | ---- | -312.50%-34K | ---- | 300.00%16K | ---- | 94.63%-8K | ---- | -386.54%-149K |
Net Cash | -85.13%-3.47M | -144.72%-2.15M | -189.42%-1.88M | 153.53%4.8M | 966.94%2.1M | -230.29%-8.97M | -106.87%-242K | 164.77%6.88M | 163.27%3.52M | -740.82%-10.63M |
Begining period cash | -22.92%7.45M | 97.44%9.66M | 97.44%9.66M | -64.67%4.89M | -64.67%4.89M | 98.67%13.85M | 98.67%13.85M | -60.73%6.97M | -60.73%6.97M | -6.39%17.75M |
Cash at the end | -48.97%3.97M | -22.92%7.45M | 11.34%7.78M | 97.44%9.66M | -48.61%6.99M | -64.67%4.89M | 29.65%13.6M | 98.67%13.85M | -13.84%10.49M | -60.73%6.97M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.